These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7638523)

  • 1. Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.
    Gripp FM; Quak J; Leverstein H; Schrijvers A; Gerretsen M; Brakenhoff R; Van Dongen G; Snow GB; Rapoport A
    Sao Paulo Med J; 1994; 112(3):612-21. PubMed ID: 7638523
    [No Abstract]   [Full Text] [Related]  

  • 2. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
    Quak J; van Dongen G
    Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
    Breitz HB
    J Nucl Med; 2000 Dec; 41(12):2011-4. PubMed ID: 11138686
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck?
    Hyde N; Prvulovich E
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):579-84. PubMed ID: 11976794
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise FDG in diagnosis and surveillance of head and neck cancer.
    Mancuso AA; Drane WE; Mukherji SK
    Cancer; 1994 Aug; 74(4):1193-5. PubMed ID: 8055436
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
    Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
    Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.
    Colnot DR; Quak JJ; Roos JC; de Bree R; Wilhelm AJ; Snow GB; van Dongen GA
    Head Neck; 2001 Jul; 23(7):559-65. PubMed ID: 11400244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
    Jereczek-Fossa BA; Jassem J; Orecchia R
    Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of FDG-PET in head-and-neck cancer with neck metastasis after definitive radiation treatment: in regard to Yao et al. (Int J Radiat Oncol Biol Phys 2005;63:991-999).
    Wang TF; Tsai EL; Kao RH
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):633; author reply 633-4. PubMed ID: 16690448
    [No Abstract]   [Full Text] [Related]  

  • 13. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck.
    Stoeckli SJ; Steinert H; Pfaltz M; Schmid S
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):221-6. PubMed ID: 11555757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic evaluation of Ga67 scanning of recurrences of head and neck carcinomas.
    Basso-Ricci S; Turrin A
    Rays; 1985; 10(2):103-8. PubMed ID: 3870489
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node localization in head and neck tumors.
    Pitman KT
    Semin Nucl Med; 2005 Oct; 35(4):253-6. PubMed ID: 16150245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    Radiother Oncol; 1997 Sep; 44(3):283-93. PubMed ID: 9380829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
    Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
    Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
    van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
    Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of radioimmunotherapy of head and neck cancer.
    Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
    Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.